MAP2K7 and lung cancer: Existing studies indicate that salidroside may upregulate miR-195, modulating the Protein kinase B (AKT) and MEK/ERK signaling pathways, or enhance miR-103-3p to target the Marginal zone B-and B1-cell-specific protein (Mzb1), thereby suppressing lung cancer proliferation and metastasis (46, 47).